Video Experimental Relacionado
Updated: Jun 2, 2026
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
La cirrosis biliar primaria es una cirrosis biliar primaria
Carlo Selmi1, Christopher L Bowlus, M Eric Gershwin
1Department of Translational Medicine, IRCCS-Istituto Clinico Humanitas, University of Milan, Milan, Italy.
Lancet (London, England)
|May 3, 2011
Resumen
La cirrosis biliar primaria (CBP) es una enfermedad hepática autoinmune diagnosticada por anticuerpos antimitocondriales (AMAs). El tratamiento con ácido ursodeoxicólico mejora el pronóstico, pero se necesitan terapias alternativas para los que no responden.
Área de la Ciencia:
- Hepatología Hepatología.
- La autoinmunología es autoinmunología.
- Gastroenterología y Gastroenterología.
Sus antecedentes:
- La cirrosis biliar primaria (CBP) es una enfermedad hepática autoinmune crónica caracterizada por la destrucción del conducto biliar intrahepático.
- La evidencia sugiere que tanto la predisposición genética como los factores ambientales (productos químicos, infecciones) contribuyen a la patogénesis de la CBP.
- El aumento de la incidencia puede estar relacionado con la mejora de las pruebas de diagnóstico en lugar de un verdadero aumento en la aparición de la enfermedad.
Objetivo del estudio:
- Para resumir la comprensión actual de la fisiopatología, el diagnóstico y el manejo de la cirrosis biliar primaria (CBP).
- Para resaltar el papel de los anticuerpos antimitocondriales (AMAs) en el diagnóstico.
- Para discutir el impacto del tratamiento con ácido ursodeoxicólico (UDCA) y la necesidad de terapias alternativas.
Principales métodos:
- Revisión de la literatura existente sobre la cirrosis biliar primaria.
- Análisis de marcadores de diagnóstico, incluidos los anticuerpos antimitocondriales (AMAs).
- Evaluación de los resultados del tratamiento con ácido ursodeoxicólico (UDCA).
Principales resultados:
- Los anticuerpos antimitocondriales (AMAs) son el sello diagnóstico para la mayoría de los casos de cirrosis biliar primaria (CBP), lo que permite la detección temprana.
- El ácido ursodeoxicólico (UDCA) es el tratamiento primario, ralentizando la progresión de la enfermedad y mejorando el pronóstico.
- Un subconjunto de pacientes muestra una respuesta inadecuada a la UDCA, lo que requiere la exploración de estrategias terapéuticas alternativas.
Conclusiones:
- La cirrosis biliar primaria (CBP) es una enfermedad hepática autoinmune compleja con etiología multifactorial.
- El diagnóstico temprano y el tratamiento con UDCA han mejorado significativamente los resultados de los pacientes.
- La investigación adicional en tratamientos alternativos es crucial para los pacientes que no responden a las terapias actuales.
Videos de Conceptos Relacionados
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...